71 related articles for article (PubMed ID: 27448773)
1. Steric structure-activity relationship of cyproheptadine derivatives as inhibitors of histone methyltransferase Set7/9.
Fujiwara T; Ohira K; Urushibara K; Ito A; Yoshida M; Kanai M; Tanatani A; Kagechika H; Hirano T
Bioorg Med Chem; 2016 Sep; 24(18):4318-4323. PubMed ID: 27448773
[TBL] [Abstract][Full Text] [Related]
2. Development of Novel Inhibitors for Histone Methyltransferase SET7/9 based on Cyproheptadine.
Hirano T; Fujiwara T; Niwa H; Hirano M; Ohira K; Okazaki Y; Sato S; Umehara T; Maemoto Y; Ito A; Yoshida M; Kagechika H
ChemMedChem; 2018 Aug; 13(15):1530-1540. PubMed ID: 29882380
[TBL] [Abstract][Full Text] [Related]
3. Identification of Cyproheptadine as an Inhibitor of SET Domain Containing Lysine Methyltransferase 7/9 (Set7/9) That Regulates Estrogen-Dependent Transcription.
Takemoto Y; Ito A; Niwa H; Okamura M; Fujiwara T; Hirano T; Handa N; Umehara T; Sonoda T; Ogawa K; Tariq M; Nishino N; Dan S; Kagechika H; Yamori T; Yokoyama S; Yoshida M
J Med Chem; 2016 Apr; 59(8):3650-60. PubMed ID: 27088648
[TBL] [Abstract][Full Text] [Related]
4. Structures of histone methyltransferase SET7/9 in complexes with adenosylmethionine derivatives.
Niwa H; Handa N; Tomabechi Y; Honda K; Toyama M; Ohsawa N; Shirouzu M; Kagechika H; Hirano T; Umehara T; Yokoyama S
Acta Crystallogr D Biol Crystallogr; 2013 Apr; 69(Pt 4):595-602. PubMed ID: 23519668
[TBL] [Abstract][Full Text] [Related]
5. Identification and Characterizations of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Scaffold Hopping- and 2D-Molecular Fingerprint-Based Similarity Search.
Ding H; Lu WC; Hu JC; Liu YC; Zhang CH; Lian FL; Zhang NX; Meng FW; Luo C; Chen KX
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498708
[TBL] [Abstract][Full Text] [Related]
6. Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7.
Min W; Hou Z; Zhang F; Xie S; Yuan K; Dong H; Wang L; Qi L; Luo C; Ding H; Yang P
Bioorg Med Chem; 2020 Apr; 28(7):115372. PubMed ID: 32088124
[TBL] [Abstract][Full Text] [Related]
7. Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors.
Hou Z; Min W; Zhang R; Niu A; Li Y; Cao L; Han J; Luo C; Yang P; Ding H
Bioorg Med Chem Lett; 2020 May; 30(9):127061. PubMed ID: 32173197
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening.
Meng F; Cheng S; Ding H; Liu S; Liu Y; Zhu K; Chen S; Lu J; Xie Y; Li L; Liu R; Shi Z; Zhou Y; Liu YC; Zheng M; Jiang H; Lu W; Liu H; Luo C
J Med Chem; 2015 Oct; 58(20):8166-81. PubMed ID: 26390175
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.
Liu F; Chen X; Allali-Hassani A; Quinn AM; Wasney GA; Dong A; Barsyte D; Kozieradzki I; Senisterra G; Chau I; Siarheyeva A; Kireev DB; Jadhav A; Herold JM; Frye SV; Arrowsmith CH; Brown PJ; Simeonov A; Vedadi M; Jin J
J Med Chem; 2009 Dec; 52(24):7950-3. PubMed ID: 19891491
[TBL] [Abstract][Full Text] [Related]
10. Role of SET7/9 in the progression of ischemic renal injury in diabetic and non-diabetic rats.
Sharma N; Sankrityayan H; Kale A; Gaikwad AB
Biochem Biophys Res Commun; 2020 Jul; 528(1):14-20. PubMed ID: 32448511
[TBL] [Abstract][Full Text] [Related]
11. Development of novel bisubstrate-type inhibitors of histone methyltransferase SET7/9.
Mori S; Iwase K; Iwanami N; Tanaka Y; Kagechika H; Hirano T
Bioorg Med Chem; 2010 Dec; 18(23):8158-66. PubMed ID: 21036620
[TBL] [Abstract][Full Text] [Related]
12. Using 'biased-privileged' scaffolds to identify lysine methyltransferase inhibitors.
Kashyap S; Sandler J; Peters U; Martinez EJ; Kapoor TM
Bioorg Med Chem; 2014 Apr; 22(7):2253-60. PubMed ID: 24650704
[TBL] [Abstract][Full Text] [Related]
13. Histone lysine methyltransferase SET7/9: formation of a water channel precedes each methyl transfer.
Zhang X; Bruice TC
Biochemistry; 2007 Dec; 46(51):14838-44. PubMed ID: 18044969
[TBL] [Abstract][Full Text] [Related]
14. Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors.
Milite C; Feoli A; Viviano M; Rescigno D; Mai A; Castellano S; Sbardella G
ChemMedChem; 2016 Aug; 11(16):1680-5. PubMed ID: 27411844
[TBL] [Abstract][Full Text] [Related]
15. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
[TBL] [Abstract][Full Text] [Related]
16. Structure-Activity Relationship Studies on (R)-PFI-2 Analogues as Inhibitors of Histone Lysine Methyltransferase SETD7.
Lenstra DC; Damen E; Leenders RGG; Blaauw RH; Rutjes FPJT; Wegert A; Mecinović J
ChemMedChem; 2018 Jul; 13(14):1405-1413. PubMed ID: 29869845
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of product specificity of AdoMet methylation catalyzed by lysine methyltransferases: transcriptional factor p53 methylation by histone lysine methyltransferase SET7/9.
Zhang X; Bruice TC
Biochemistry; 2008 Mar; 47(9):2743-8. PubMed ID: 18260647
[TBL] [Abstract][Full Text] [Related]
18. Structure and catalytic mechanism of the human histone methyltransferase SET7/9.
Xiao B; Jing C; Wilson JR; Walker PA; Vasisht N; Kelly G; Howell S; Taylor IA; Blackburn GM; Gamblin SJ
Nature; 2003 Feb; 421(6923):652-6. PubMed ID: 12540855
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the methylation site specificity of SET7/9.
Couture JF; Collazo E; Hauk G; Trievel RC
Nat Struct Mol Biol; 2006 Feb; 13(2):140-6. PubMed ID: 16415881
[TBL] [Abstract][Full Text] [Related]
20. Catalytic mechanism and product specificity of the histone lysine methyltransferase SET7/9: an ab initio QM/MM-FE study with multiple initial structures.
Hu P; Zhang Y
J Am Chem Soc; 2006 Feb; 128(4):1272-8. PubMed ID: 16433545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
